SESemyon V. Efimov

Semyon V. Efimov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Semyon V. Efimov has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic significance of determining hypoxiainduced factor 1 alpha in hypoxia of various severity

    by D. D. Bykova, A. V. Lyubimov, A. S. Tarakhteev, S. V. Efimov

    Diagnostic significance of determining hypoxiainduced factor 1 alpha in hypoxia of various severity | Bykova | New St. Petersburg Medical Records Диагностическая значимость определения гипоксией индуцированного фактора 1 альфа при гипоксии различной степени тяжест | Быкова | Новые Санкт-Петербургские врачебные ведомости

  • Open Access

    Vascular age as an integral indicator of early heart and vascular remodeling after traumatic limb amputation

    by Semyon V. Efimov, Ефимов Семен Валерьевич, Andrey V. Lyubimov, Любимов Андрей Владимирович, Dmitry V. Cherkashin, Черкашин Дмитрий Викторович, Anton S. Tarakhteev, Тарахтеев Антон Сергеевич, Diana D. Tarakhteevа, Тарахтеева Диана Дмитриевна, et al.

    Background: Traumatic limb amputation is associated with an increased cardiovascular risk, but the mechanisms and methods for early diagnosis of heart and vascular remodeling are insufficiently understood. The concept of vascular age may offer an integral approach to the assessment of maladaptive changes. AIM: To assess the structural and functional state of the cardiovascular system and cardiovascular risk in patients with traumatic limb amputation and to determine their contribution to increased vascular age to provide a rationale for early prevention and treatment strategies. METHODS: We examined 127 men of young and middle age (main group: 45 patients with post-traumatic amputation; control: 82 individuals undergoing routine check-ups). All underwent echocardiography with global longitudinal strain analysis, volumetric sphygmography, 24-hour ECG and blood pressure monitoring, and risk assessment using QRISK3, SCORE2, and SCORE to determine vascular age. Statistical significance was set at p 0.05. RESULTS: Patients with amputation had increased aortic root diameter (35.5 mm vs 33.0, p 0.001), ascending aorta (32.5 mm vs 30.0, p = 0.015), and aortic arch (29.0 mm vs 27.0, p = 0.003), reduced global longitudinal strain (–17.75% vs –19.55%, p 0.001), increased vascular stiffness (R/L-CAVI 7.2 vs 6.45, p = 0.015; R/L-AI 0.92 vs 0.74, p 0.001), and higher systolic pulmonary artery pressure (23 mmHg vs 18, p 0.001). Heart rate variability (SDNN 123 ms vs 194.7, p 0.001; RMSSD 24 ms vs 53.8, p 0.001) and the circadian index (1.1 vs 1.3, p 0.001) were lower. QRISK3 score was higher in the main group (1.6% vs 0.9, p = 0.002). Vascular age by SCORE (in those aged 40 years) was 49 years vs 44 in controls (p = 0.049), and by sphygmography it was 42 years vs 32 (p = 0.019). CONCLUSION: Traumatic amputation is associated with a spectrum of early cardiovascular changes (aortic and myocardial remodeling, increased vascular stiffness, and autonomic dysfunction), resulting in increased vascular age. Assessment of vascular age may serve as an integral risk marker and a basis for preventive measures.

  • The significance of positional changes in spirometric parameters in unilateral diaphragm dysfunction

    by N.V. Sharova, D.V. Cherkashin, A.D. Sobolev, S.V. Efimov, I.M. Zakharova, K.N. Tkachenko

    Aim. To evaluate the diagnostic significance of positional changes in the vital capacity of the lungs (ΔVC) and forced vital capacity of the lungs (ΔFVC) in the verification of unilateral diaphragm dysfunction, confirmed by radiographic data and ultrasound examination results. Design. Comparative observational prospective study Materials and methods. The study was conducted at the Naval Therapy Clinic of the S.M. Kirov Military Medical Academy from March 2021 to January 2025. The study group consisted of 44 patients with medical conditions complicated by unilateral diaphragmatic dysfunction: 12 with complete diaphragmatic dysfunction and 32 with partial diaphragmatic dysfunction. The control group included 20 patients with comparable conditions and no signs of respiratory muscle damage. According to the developed algorithm, all participants underwent a comprehensive examination, including chest X-ray and computed tomography, diaphragm ultrasound, and spirometry. Baseline lung volumes and their positional changes were assessed: ΔVC (%), ΔFVC (%), and forced expiratory volume in the first second (ΔFEV1, %). Results. In case of complete diaphragm dysfunction, a decrease in VCF to 66.0 [58.6; 85.9] % (FVC to 73.5 [63.4; 87.3] %) and a positional decrease in ΔVC% by –16.5 [–25.1; –9.4] % (ΔFVC% by –11.0 [–25.4; –6.3] %) were detected. In case of partial diaphragm dysfunction, the figures were statistically significantly higher: VCF was 80.5 [75.5; 91.2] % (FVC — 76.0 [72.0; 88.4] %) and a positional decrease in ΔVC% by –5.0 [–9.5; –0.4] % (ΔFVC% by –9.7 [–13.0; –5.6] %). In 12 patients with unilateral complete dysfunction, ultrasound examination revealed a combined decrease in diaphragmatic excursion and fractional thickening to 17.0% on the affected side. A statistically significant negative correlation of moderate strength (p = 0.028 and p = 0.04) was established between ΔVC (ΔFVC) and fractional thickening, confirming the involvement of the diaphragm in the genesis of positional changes. The results of dynamic observation indicate the feasibility of individualized assessment of spirometric and positional parameters (ΔVC, ΔFVC, ΔFEV1) for monitoring the functional status of these patients. Conclusion. A positional decrease in the indicators by more than 15%, combined with a decrease in baseline VC and FVC values, can be considered as a diagnostic criterion for unilateral complete diaphragmatic dysfunction. Furthermore, identifying a group of patients with partial diaphragmatic dysfunction allows for a more precise characterization of functional impairment, even in mild cases. In cases where the positional decrease in ΔVC and ΔFVC ranges from 10 to 15%, confirmation of the diagnosis by ultrasound is mandatory. A comprehensive assessment of positional changes in lung volumes and ΔVC and ΔFVC indicators is useful for monitoring the functional status of patients with unilateral diaphragmatic dysfunction during treatment and follow-up. Keywords: unilateral complete dysfunction of the diaphragm, unilateral partial dysfunction of the diaphragm, positional changes, ΔVC, ΔFVC, fractional thickening of the diaphragm.

  • Open Access

    Hypoxia and novel coronavirus infection: Hypoxia-inducible factor 1-alpha as marker of disease severity and new therapeutic target

    by Semyon V. Efimov, Andrey V. Lyubimov, Dmitry V. Cherkashin, Anton S. Tarachteev, Diana D. Bykova, Vladislav V. Vasiliev, Aleksandra E. Trandina, Elena A. Pogozhaya, Любимов Андрей Владимирович

    BACKGROUND: Hypoxia has been identified as a crucial factor in the pathogenesis of the novel coronavirus infection, with studies demonstrating its role in inflammatory processes and complications. Hypoxia-inducible factor 1-alpha plays a critical role in regulating the body’s adaptation to oxygen deficiency. A comprehensive investigation of variations in hypoxia-inducible factor 1-alpha in patients with new coronavirus infection allows for elucidating the pathogenetic mechanisms of the disease and identifying promising therapeutic targets. AIM: The work aimed to evaluate the role of hypoxia-inducible factor 1-alpha in the compensation and adaptation of the body to hypoxic stress during novel coronavirus infection. METHODS: From January 2020 to March 2022, 295 patients were assessed at the Naval Therapy Clinic of the Kirov Military Medical Academy, with 272 of them diagnosed with the novel coronavirus infection. The patients were divided into three age groups based on the World Health Organization’s classification: group 1, young age (207 patients); group 2, middle age, (56 patients); and group 3, elderly age (32 patients). Serum hypoxia-inducible factor 1-alpha was measured using an enzyme immunoassay. Statistical data were processed using GraphPad Prism 8 and IBM SPSS Statistics. Statistical significance was set at p 0.05. RESULTS: Hypoxia-inducible factor 1-alpha correlated with both age and novel coronavirus infection severity, peaking among elderly patients with severe forms of the disease. Hypoxia-inducible factor 1-alpha decreased during recovery, indicating the adaptive response to hypoxic stress termination. In the group of elderly patients, higher hypoxia-inducible factor 1-alpha values were associated with mild novel coronavirus infection, which was related to existing comorbidities. CONCLUSION: The findings corroborate the hypothesis that hypoxia-inducible factor 1-alpha is a valuable prognostic marker for hypoxic complication severity in patients with the novel coronavirus infection and confirm its potential as a therapeutic target. Further studies are needed to elucidate the molecular mechanisms of its regulation and develop pharmacological treatment strategies for hypoxic disorders.

  • Open Access

    Erythropoietin as antihypoxic cytokine

    by Andrey V. Lyubimov, Diana D. Bykova, Anton S. Tarachteev, Evgeniy V. Ivchenko, Semen V. Efimov, Любимов Андрей Владимрович

    This study analyzed the potential for the widespread use of erythropoietin, the main antihypoxic cytokine produced by renal parenchyma cells, and possible complications associated with its use. Erythropoietin is a glycoprotein heterodimer whose main function is the regulation of the formation and differentiation of erythroid germ cells and formation of the primary physiological response to hypoxia. The main effects of this cytokine are summarized, and the main points of application of the hormone, mechanisms of content regulation, and its use in medicine as a natural pharmacological agent in pharmacological preconditioning are highlighted. Attention is also drawn to the increasing role of hypoxia — one of the most dangerous typical pathological processes in the formation of life-threatening conditions, which has found its use in medicine, particularly as a physiological agent in combating vascular diseases, which are gaining enormous importance in our time.

  • Associations of polymorphisms of the ACE and ACE2 genes with clinical manifestations and cardiovascular complications of the coronavirus infection

    by Dmitriy S. Bogdanov, Dmitriy V. Cherkashin, Semen V. Efimov, Alevtina I. Zakharova

    A problem of the novel coronavirus infection pandemic is the absence of specific biomarkers, the determination of which would make it possible to assess the likelihood of a severe disease course, development of complications, immediate and long-term consequences, and effective etiotropic (antiviral) therapy. The severity of the novel coronavirus infection depends on various factors such as the initial state of health, immune status, age, smoking status, concomitant cardiovascular diseases, and diabetes mellitus. However, a severe disease course is also observed in patients without the aforementioned risk factors. The development of the disease and its complications depends on sex and geographical identity. Angiotensin-converting enzyme 2 (ACE2), associated by gene-gene interaction with ACE, plays a main role in the pathogenesis of the penetration of severe acute respiratory syndrome-2 coronavirus into the cell. The main body of information on this problem is represented by systematic meta-analyses and results of single-center cohort studies, which offer insufficient information to unequivocally assert the associations of ACE and ACE2 gene polymorphisms with pathological changes in the circulatory system during and after a new coronavirus infection. Differences in the incidence of ACE and ACE2 alleles may explain the differences between susceptible populations and/or response to the severe coronavirus infection. The above studies were carried out on the effect of the coronavirus in the initial period of the pandemic. For a more complete molecular genetic picture of the influence of polymorphism, persons with different strains of the coronavirus must be considered. In addition, no data are available regarding the expressions of ACE and ACE2 genes in response to a coronavirus infection. Moreover, the identification of the polymorphic variants of the genes of the reninangiotensinaldosterone system and ACE2 associated with a high risk of developing and worsening cardiovascular diseases may be one of the promising areas for the early diagnosis and prevention of post-COVID-19 changes. Therefore, all scientific interest research is aimed at studying genetic factors, such as single nucleotide polymorphisms that affect susceptibility to infection, severity of the disease course, and development of circulatory system consequences. In general, polymorphic variants of ACE and ACE2 and their interaction will help us understand this problem and systematize knowledge for further research in this area.


  • Open Access

    Features and significance of the early bronchodilatation effect of the first dose of a long-acting bronchodilator alone and in fixed combination in the treatment of chronic obstructive pulmonary disease

    by Natalia V. Sharova, Dmitriy V. Cherkashin, Sergey L. Grishayev, Semen V. Efimov, Mikhail A. Kharitonov, Sayera A. Turdialieva, Гришаев Сергей Леонидович, Харитонов Михаил Анатольевич

    The early bronchodilatory effects of the first dose of long-acting anticholinergics (glycopyrronium and tiotropium) were compared with those of a fixed double combination of long-acting bronchodilators of various classes (indacaterol/glycopyrronium) in patients with stable chronic obstructive pulmonary disease. The possibility of using the results of an early bronchodilatory response to predict their effectiveness in the basic therapy of chronic obstructive pulmonary disease is evaluated. A total of 176 patients with chronic obstructive pulmonary disease were examined. The patients were randomized into three groups. The first group (n = 66) took glycopyrronium, the second group (n = 60) received a combination of indacaterol/glycopyrronium, and the third group (n = 50, control) took tiotropium. Broncholytic tests with the listed drugs were evaluated. The early bronchodilatory effect of the first dose of 110/50 mcg indacaterol/glycopyrronium was manifested by significant bronchodilation (p 0.001) from 30 min, reached its maximum value 60 min after drug intake, and persisted after a 28-day course of treatment. The combination of indacaterol/glycopyrronium provided rapid and prolonged bronchodilation in patients with stable chronic obstructive pulmonary disease, demonstrating advantages over the isolated use of glycopyrronium and tiotropium. Maximization of bronchodilation by the sequential use of glycopyrronium and salbutamol leads to an increase in the volume of forced exhalation in the first second on the 90th min, comparable with the results of indacaterol/glycopyrronium on the 60th min after drug intake, which indicates the clinical feasibility of maximizing bronchodilation with drugs both separately and in combination. Based on a direct positive correlation between the initial value of the forced expiratory volume in the first second and the value on day 28 of indacaterol/glycopyrronium therapy, an equation for predicting the individual effectiveness of the drug during treatment is derived.

  • Open Access

    Mechanisms and triggers of adaptation to hypoxia

    by Andrey V. Lyubimov, Dmitriy V. Cherkashin, Semen V. Efimov, Andrey E. Alanichev, Valeriy S. Ivanov, Gennadiy G. Kutelev, Любимов Андрей Владимирович

    It is believed that hypoxia-induced factor (HIF1) is the key mediator of oxygen metabolism. It was first identified as a transcription factor activated in cells and tissues by lowering the partial pressure of oxygen (O2). The HIF1 activator spectrum includes both external factors hypoxia, psycho-emotional stress and in ternal factors and varies from hormones to iron chelators. This review is dedicated to the molecular mechanisms of HIF1 activation, some of its natural activators HIF1, the potential for which is due to the low level of toxicity and the reduced likelihood of undesirable side effects. In turn, this opens up new options to treat diseases associated with local and general ischemia and hypoxia, the possibilities of their prophylactic use for researchers and clinicians in order to reduce the degree of damage in the event of an unforeseen condition of acute injurious to organs and tissues by hypoxia and reperfusion after it.


  • Differentiated approach to the implementation of preventive and anti-epidemic measures among military personnel based on the COVID-19 disease risk assessment scale

    by Military Medical Academy Named After S.M. Kirov Of The Ministry Of Defense Of The Russian Federation, E.V. Kryukov, D.V. Cherkashin, I.A. Reutskiy, V.N. Solntsev, S.A. Bucenko, A.D. Sobolev, B.V. Levankov, M.V. Dmitriev, S.V. Efimov, et al.

    Дифференцированный подход к проведению профилактических и противоэпидемических мероприятий среди военнослужащих на основе шкалы оценки рисков